{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:05:33Z","timestamp":1783569933944,"version":"3.55.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1097\/cad.0b013e32835f258d","type":"journal-article","created":{"date-parts":[[2013,2,26]],"date-time":"2013-02-26T15:44:39Z","timestamp":1361893479000},"page":"461-472","source":"Crossref","is-referenced-by-count":12,"title":["Recombinant snake venom metalloproteinase inhibitor BJ46A inhibits invasion and metastasis of B16F10 and MHCC97H cells through reductions of matrix metalloproteinases 2 and 9 activities"],"prefix":"10.1097","volume":"24","author":[{"given":"Ming-Kai","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Wen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Yin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210203","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10555-010-9237-0","article-title":"Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer.","volume":"29","author":"Deep","year":"2010","journal-title":"Cancer Metastasis Rev"},{"key":"R2-4-20210203","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1742-4658.2010.07919.x","article-title":"Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting.","volume":"278","author":"Gialeli","year":"2011","journal-title":"FEBS J"},{"key":"R3-4-20210203","first-page":"209","article-title":"Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.","volume":"103","author":"Benjamin","year":"2012","journal-title":"EXS"},{"key":"R4-4-20210203","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.toxicon.2009.03.017","article-title":"Snake venom inhibits the growth of mouse mammary tumor cells in vitro and in vivo.","volume":"54","author":"El-Refael","year":"2009","journal-title":"Toxicon"},{"key":"R5-4-20210203","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.toxicon.2009.12.004","article-title":"Renal and cardiovascular effects of Bothrops marajoensis venom and phospholipase A2.","volume":"55","author":"Evangelista","year":"2010","journal-title":"Toxicon"},{"key":"R6-4-20210203","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1046\/j.1432-1327.2001.02199.x","article-title":"A snake venom metalloproteinase inhibitor. Isolation, characterization, cloning and insights into its mechanism of action.","volume":"268","author":"Valente","year":"2001","journal-title":"Eur J Biochem"},{"key":"R7-4-20210203","first-page":"755","article-title":"Gene synthesis and construction of baculovirus expression vector of a snake venom metalloproteinase inhibitor.","volume":"25","author":"Xu","year":"2006","journal-title":"Chin J Biomed Eng"},{"key":"R8-4-20210203","first-page":"28","article-title":"Inhibition effect of a snake venom metalloproteinase inhibitor on experimental pulmonary metastasis in mice inoculated with B16 melanoma cells.","volume":"29","author":"Xu","year":"2009","journal-title":"China Biotechnol"},{"key":"R9-4-20210203","first-page":"749","article-title":"Recombinant protein exerts inhibition effect on invasion and metastasis of B16 cells in vitro.","volume":"40","author":"Xu","year":"2009","journal-title":"Acta Anat Sin"},{"key":"R10-4-20210203","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s10930-012-9392-y","article-title":"High-level expression, purification, characterization and structural prediction of a snake venom metalloproteinase inhibitor in Pichia pastoris.","volume":"31","author":"Shi","year":"2012","journal-title":"Protein J"},{"key":"R11-4-20210203","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/sj.bjc.6690769","article-title":"New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.","volume":"81","author":"Tian","year":"1999","journal-title":"Br J Cancer"},{"key":"R12-4-20210203","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/sj.bjc.6600461","article-title":"Granulocytes mediates the Fas-L-associated apoptosis during lung metastasis of melanoma that determines the metastatic behaviour.","volume":"87","author":"Chen","year":"2002","journal-title":"Br J Cancer"},{"key":"R13-4-20210203","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/1534735407302345","article-title":"Effect of amentoflavone on the inhibition of pulmonary metastasis induced by B16F10 melanoma cells in C57BL6 mice.","volume":"6","author":"Guruvayoorappan","year":"2007","journal-title":"Integr Cancer Ther"},{"key":"R14-4-20210203","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1021\/bp070294t","article-title":"Expression system for synthesis and purification of recombinant human growth hormone in Pichia pastoris and structural analysis by MALDI-ToF mass spectrometry.","volume":"24","author":"Calik","year":"2008","journal-title":"Biotechnol Prog"},{"key":"R15-4-20210203","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0003-2697(89)90115-2","article-title":"Characterization of glycoproteins and their associated oligosaccharides through the use of endoglycosidases.","volume":"180","author":"Maley","year":"1989","journal-title":"Anal Biochem"},{"key":"R16-4-20210203","first-page":"3809","article-title":"Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo.","volume":"19","author":"Della Porta","year":"1999","journal-title":"Anticancer Res"},{"key":"R17-4-20210203","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000339645","article-title":"Urinary matrix metalloproteinase activity in diabetic kidney disease: a potential marker of disease progression.","volume":"2","author":"Altemtam","year":"2012","journal-title":"Nephron Extra"},{"key":"R18-4-20210203","first-page":"107","article-title":"Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.","volume":"15","author":"Gil-Ad","year":"2006","journal-title":"Oncol Rep"},{"key":"R19-4-20210203","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.toxicon.2011.02.002","article-title":"Recombinant snake venom cystatin inhibits the growth, invasion and metastasis of B16F10 cells and MHCC97H cells in vitro and in vivo.","volume":"57","author":"Xie","year":"2011","journal-title":"Toxicon"},{"key":"R20-4-20210203","first-page":"7724","article-title":"Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer.","volume":"63","author":"Tu","year":"2003","journal-title":"Cancer Res"},{"key":"R21-4-20210203","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-1-60327-517-0_10","article-title":"Zymographical techniques for detection of matrix metalloproteinases.","volume":"477","author":"Iwai","year":"2008","journal-title":"Methods Mol Biol"},{"key":"R22-4-20210203","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pep.2007.03.008","article-title":"Cloning, expression, purification and functional characterization of recombinant human PSP94.","volume":"54","author":"Garde","year":"2007","journal-title":"Protein Expr Purif"},{"key":"R23-4-20210203","first-page":"87","article-title":"Inferring the phylogenetic position of Brugia pahangi using 18S ribosomal RNA (18S rRNA) gene sequence.","volume":"25","author":"Fong","year":"2008","journal-title":"Trop Biomed"},{"key":"R24-4-20210203","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10529-007-9610-4","article-title":"Purification and bioactivity of exendin-4, a peptide analogue of GLP-1, expressed in Pichia pastoris.","volume":"30","author":"Zhou","year":"2008","journal-title":"Biotechnol Lett"},{"key":"R25-4-20210203","first-page":"467","article-title":"High-level expression of an Aspergillus niger endo--1,4-glucanase in Pichia pastoris through gene codon optimization and synthesis.","volume":"20","author":"Shumiao","year":"2010","journal-title":"J Microbiol Biotechnol"},{"key":"R26-4-20210203","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1016\/j.biortech.2011.04.070","article-title":"A thermotolerant and cold-active mannan endo-1,4--mannosidase from Aspergillus niger CBS 513.88: constitutive overexpression and high-density fermentation in Pichia pastoris.","volume":"102","author":"Zhao","year":"2011","journal-title":"Bioresour Technol"},{"key":"R27-4-20210203","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jnci\/93.3.178","article-title":"Development of matrix metalloproteinase inhibitors in cancer therapy.","volume":"93","author":"Hidalgo","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"R28-4-20210203","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/A:1005722729132","article-title":"Matrix metalloproteinase inhibitors.","volume":"15","author":"Wojtowicz-Praga","year":"1997","journal-title":"Invest New Drugs"},{"key":"R29-4-20210203","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1699-0463.1999.tb01541.x","article-title":"Clinical studies with matrix metalloproteinase inhibitors.","volume":"107","author":"Brown","year":"1999","journal-title":"APMIS"},{"key":"R30-4-20210203","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1749-6632.1999.tb07689.x","article-title":"Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials.","volume":"878","author":"Shalinsky","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"R31-4-20210203","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1749-6632.1999.tb07690.x","article-title":"MMP inhibition in prostate cancer.","volume":"878","author":"Lokeshwar","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"R32-4-20210203","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1515\/BC.2001.124","article-title":"Characterization of C-terminally truncated human tissue inhibitor of metalloproteinases-4 expressed in Pichia pastoris.","volume":"382","author":"Bernd","year":"2001","journal-title":"Biol Chem"},{"key":"R33-4-20210203","doi-asserted-by":"crossref","first-page":"15025","DOI":"10.1021\/bi026454l","article-title":"E. coli expression of TIMP-4 and comparative kinetic studies with TIMP-1 and TIMP-2: insights into the interactions of TIMPs and matrix metalloproteinase 2.","volume":"41","author":"Troeberg","year":"2002","journal-title":"Biochemistry"},{"key":"R34-4-20210203","first-page":"3629","article-title":"Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models.","volume":"55","author":"Watson","year":"1995","journal-title":"Cancer Res"},{"key":"R35-4-20210203","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00726-010-0689-x","article-title":"Physiology and pathophysiology of matrix metalloproteases.","volume":"41","author":"Klein","year":"2011","journal-title":"Amino Acids"},{"key":"R36-4-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bdrc.20065","article-title":"Matrix metalloproteinases in development and disease.","volume":"78","author":"Lemaitre","year":"2006","journal-title":"Birth Defects Res C Embryo Today"},{"key":"R37-4-20210203","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.prp.2011.09.010","article-title":"Matrix metalloproteinase-2 (MMP-2) and MMP-9 expression in invasive ductal carcinoma of the breast.","volume":"207","author":"Sullu","year":"2011","journal-title":"Pathol Res Pract"},{"key":"R38-4-20210203","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1096\/fasebj.13.8.781","article-title":"Regulation of matrix metalloproteinase expression in tumor invasion.","volume":"13","author":"Westermarck","year":"1999","journal-title":"FASEB J"},{"key":"R39-4-20210203","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s12272-011-0512-6","article-title":"Expression of snake venom cystatin in human MHCC97H cells inhibits invasion and metastasis through reduction of proteinases activity and epithelial-mesenchymal transition.","volume":"34","author":"Tang","year":"2011","journal-title":"Arch Pharm Res"},{"key":"R40-4-20210203","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/37995","article-title":"Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.","volume":"389","author":"Gomis-Ruth","year":"1997","journal-title":"Nature"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CAD.0b013e32835f258d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:18:08Z","timestamp":1620947888000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001813-201306000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e32835f258d","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}